Filtros de búsqueda

Lista de obras de Denis Poddubnyy

A systematic comparison of rheumatoid arthritis and ankylosing spondylitis: non-steroidal anti-inflammatory drugs.

artículo científico publicado en 2009

Adalimumab for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis - a five-year update.

artículo científico

Adalimumab for the treatment of psoriatic arthritis

artículo científico publicado en 2009

Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis

artículo científico publicado en 2019

An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus

artículo científico publicado en 2018

Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria.

artículo científico publicado en 2018

Axial spondyloarthritis.

artículo científico publicado en 2017

Axial spondyloarthritis: is there a treatment of choice? ⬇️

artículo científico publicado el 1 de febrero de 2013

Balancing benefits and risks in the era of biologics

scientific article published on 24 October 2019

Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis

scientific article published on 01 May 2012

Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs.

artículo científico publicado en 2008

Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark

artículo científico publicado en 2018

Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception

artículo científico publicado en 2015

Brief Report: Course of Active Inflammatory and Fatty Lesions in Patients With Early Axial Spondyloarthritis Treated With Infliximab Plus Naproxen as Compared to Naproxen Alone: Results From the Infliximab As First Line Therapy in Patients with Earl

artículo científico publicado en 2016

Calprotectin serum level is an independent marker for radiographic spinal progression in axial spondyloarthritis

artículo científico publicado en 2014

Central reader evaluation of MRI scans of the sacroiliac joints from the ASAS classification cohort: discrepancies with local readers and impact on the performance of the ASAS criteria

scientific article published on 05 May 2020

Challenges and Advances in Targeting Remission in Axial Spondyloarthritis

artículo científico publicado en 2018

Chronic meningococcaemia-a medical oxymoron.

artículo científico publicado en 2017

Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC).

artículo científico publicado en 2013

Comment on: 'Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis' by Kuwabara et al

scientific article published on 24 June 2020

Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis

artículo científico publicado en 2010

Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial

artículo científico publicado en 2014

Correction: HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort

artículo científico publicado en 2019

Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by th

artículo científico publicado en 2015

Current Unmet Needs in Spondyloarthritis

artículo científico publicado en 2019

Decreased heart rate variability in patients with psoriatic arthritis

artículo científico publicado en 2012

Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance

artículo científico publicado en 2021

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

artículo científico publicado en 2016

Detection of Sacroiliitis by Short-tau Inversion Recovery and T2-weighted Turbo Spin Echo Sequences: Results from the SIMACT Study

artículo científico publicado en 2019

Determinants of diagnostic delay in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

artículo científico publicado en 2019

Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data

artículo científico publicado en 2018

Diagnosis and therapy of axial spondyloarthritis including ankylosing spondylitis (Bechterew's disease)

artículo científico publicado en 2012

Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care

scientific article published on 05 December 2018

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts

artículo científico publicado en 2019

Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study

scientific article published on 06 April 2020

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

scientific article published on 01 June 2020

Early axial spondyloarthritis. Diagnostic approach and screening

artículo científico publicado en 2012

Early spondyloarthritis.

artículo científico publicado en 2012

Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS).

artículo científico publicado en 2015

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.

artículo científico publicado en 2012

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: 16 Week Results of a Phase 3 Randomized, Double-Blind, Placebo Controlled Trial in Patients with Prior Inadequate Response or Intolerance to Tumor Necrosis Fa

scientific article published on 08 March 2019

Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis ⬇️

artículo científico publicado el 10 de mayo de 2011

Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial

artículo científico publicado en 2021

Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis.

artículo científico publicado en 2013

Emerging drugs for the treatment of axial spondyloarthritis.

artículo científico publicado en 2018

Emerging drugs for the treatment of noninfectious uveitis

scientific article published on 19 September 2019

Emerging treatment options for spondyloarthritis

scientific article published on 01 June 2018

Etanercept for the treatment of non-radiographic axial spondyloarthritis

artículo científico publicado en 2016

Evaluation of 2 screening strategies for early identification of patients with axial spondyloarthritis in primary care.

artículo científico publicado en 2011

Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial

artículo científico publicado en 2012

Functional relevance of radiographic spinal progression in axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort

artículo científico publicado en 2018

GRAPPA 2019 Project Report

artículo científico publicado en 2020

Golimumab for treatment of axial spondyloarthritis

artículo científico publicado en 2016

HLA-C*07 in axial spondyloarthritis: data from the German Spondyloarthritis Inception Cohort and the Spondyloarthritis Caught Early cohort

artículo científico publicado en 2019

Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis?

artículo científico publicado en 2017

High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception C

artículo científico publicado en 2016

High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis

artículo científico publicado en 2011

Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.

artículo científico publicado en 2018

IL-17 inhibition in axial spondyloarthritis: current and future perspectives

scientific article published on 19 April 2019

Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis

artículo científico publicado en 2019

Inflammation, new bone formation and treatment options in axial spondyloarthritis

scientific article published on 08 May 2014

Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trial

artículo científico publicado en 2015

Investigation of involved tissue in axial spondyloarthritis--what have we learnt from immunohistochemical studies?

artículo científico publicado en 2010

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial

scientific article published on 05 December 2019

Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study

artículo científico publicado en 2019

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group

artículo científico publicado en 2019

Magnetic resonance imaging compared to conventional radiographs for detection of chronic structural changes in sacroiliac joints in axial spondyloarthritis

artículo científico publicado en 2013

Mechanism of New Bone Formation in Axial Spondyloarthritis.

artículo científico publicado en 2017

New evidence on the management of spondyloarthritis.

artículo científico publicado en 2016

New treatment targets in ankylosing spondylitis and other spondyloarthritides ⬇️

artículo científico publicado el 1 de julio de 2011

Old and new treatment targets in axial spondyloarthritis

artículo científico publicado en 2015

Pathogenesis of spondylarthritis : Relevance for treatment

artículo científico publicado en 2020

Patient-reported Impact of Axial Spondyloarthritis on Working Life: Results from the EMAS survey

artículo científico publicado en 2020

Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis

scientific article published on 29 July 2019

Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years

artículo científico publicado en 2016

Prevention of new osteitis on magnetic resonance imaging in patients with early axial spondyloarthritis during 3 years of continuous treatment with etanercept: data of the ESTHER trial

artículo científico publicado en 2014

Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept

scientific article published on 07 March 2019

Radiographic Evaluation of Sacroiliac Joints in Axial Spondyloarthritis - Still Worth Performing?

artículo científico publicado en 2017

Radiographic progression in ankylosing spondylitis/axial spondyloarthritis: how fast and how clinically meaningful?

artículo científico

Radiographic progression in non-radiographic axial spondyloarthritis

artículo científico publicado en 2018

Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

artículo científico publicado en 2011

Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project

artículo científico publicado en 2019

Recent advances in spondyloarthritis

scientific article published on 01 June 2018

Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis -- a comprehensive genotype-phenotype analysis from an observational cohort

scientific article published on 01 September 2011

Relation of α<sub>2</sub>-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis

artículo científico publicado en 2020

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.

artículo científico publicado en 2011

Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

artículo científico publicado en 2017

Response to 'A missing pebble in the mosaic of rheumatic diseases and mental health: younger does not always mean happier' by Alunno

article

Response to: 'Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?' by Wallmann et al

artículo científico publicado en 2019

Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials

scientific article published on 23 November 2020

Secukinumab improves signs and symptoms of non-radiographic axial spondyloarthritis: primary results of a randomized controlled phase III study

artículo científico publicado en 2020

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study

artículo científico publicado en 2019

Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression.

artículo científico publicado en 2015

Shared and Distinct Gut Microbiota in Spondyloarthritis, Acute Anterior Uveitis, and Crohn's Disease

artículo científico publicado en 2023

Should we combine biologics with methotrexate in axial spondyloarthritis?

artículo científico publicado en 2019

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial

artículo científico publicado en 2012

Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment.

artículo científico publicado en 2014

Skin manifestations in spondyloarthritis

artículo científico publicado en 2020

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison

artículo científico publicado en 2019

Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.

artículo científico publicado en 2014

Study protocol: COmparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of StrUctural damage in the spine over t

artículo científico publicado en 2017

Susceptibility-weighted MR imaging to improve the specificity of erosion detection: a prospective feasibility study in hand arthritis

artículo científico publicado en 2018

The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective-an Analysis of 2846 Patients Across 13 Countries

scientific article published on 12 March 2019

The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis

artículo científico publicado en 2019

The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic

artículo científico publicado en 2012

The safety of celecoxib in ankylosing spondylitis treatment

artículo científico publicado en 2008

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study,

scientific article published on 30 September 2020

Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.

artículo científico publicado en 2017

Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).

artículo científico

Uveitis in spondyloarthritis

scientific article published on 12 September 2020

What is the best treatment target in axial spondyloarthritis: tumour necrosis factor α, interleukin 17, or both?

artículo científico publicado en 2017

Withdrawal of biologic therapy in axial spondyloarthritis: the experience in early disease

artículo científico publicado en 2013

[Advances in research on axial spondyloarthritis]

artículo científico publicado en 2018

[Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a routine data analysis]

artículo científico publicado en 2020

[Health care and disease burden in persons with axial spondyloarthritis in Germany]

scientific article published on 01 November 2019

[Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version]

scientific article published on 01 October 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda